New preclinical data show PBGENE-DMD drove up to a 3x higher dystrophin protein restoration in skeletal muscle and up to 12x higher in respiratory muscle in early-juvenile mice compared to ...

H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / May 14, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, ...

Selection recognizes Praia's platform as a proven driver of patient retention, revenue growth, and digital transformation for ...

Oversubscribed $22.5 million financing anticipated to enable CNS Pharmaceuticals to acquire differentiated, clinical-stage assets with identifiable near-term value-inflection catalysts, aligned with ...

New Black Book Research report analyzes Israel's EHR/EMR maturity, national health information exchange, AI in medicine, hospital cybersecurity, wartime continuity, digital mental health, diagnostic ...

SHANGHAI, CN / ACCESS Newswire / May 14, 2026 / Saint Bella Group recently announced that its investment in and entered a strategic partnership with L Catterton, the leading consumer-focused private ...

May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning ...

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies. The recognition highlights ...

Statewide outreach initiatives across Northern California, Southern California, the Bay Area and the Inland Empire seeks ...

First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~~ First Quarter Gross ...

The group addresses the growing complexity and volume of tech-related disputesIRVINE, Calif.--(BUSINESS WIRE)--JAMS, the premier provider of alternative dispute resolution (ADR) services worldwide, ...

Cash position of €12.0 million as of March 31, 2026Shareholder loan agreement signed with Vester Finance on April 21, 2026, securing a cash runway until the beginning of Q2 2027BioChaperone®: ...